首页> 外文会议>Society for Biomaterials annual meeting and exposition >Lyophilized Poly(ethylene glycol-b-(diniethylaminoethyl methacrylate-co-butyl methacrylate))-DNA Nanoparticles for Nonviral Gene Therapy
【24h】

Lyophilized Poly(ethylene glycol-b-(diniethylaminoethyl methacrylate-co-butyl methacrylate))-DNA Nanoparticles for Nonviral Gene Therapy

机译:冻干聚乙二醇-b-(甲基丙烯酸二乙胺基乙基乙基-甲基丙烯酸丁酯)-DNA纳米粒子用于非病毒基因治疗

获取原文

摘要

Novel poly(EG-b-(DMAEMA-co-BMA))-pDNA nanoparticles were shown to be stable after lyophilization and incubation in PBS and efficiently transfect cells in vitro. Except for 50L, complexes with N/P ratios of 10 and 20 had smaller sizes after lyophilization than Hpofectamine2000 and PEI and higher transfection efficiency than PEI. The time constants for aggregation determined from the exponential fits provide quantitative evidence for the increased stability of poly(EG-b-(DMAEMA-co-BMA)) complexes compared to Iipofectamine2000 and PEI. Future work will involve incorporating lyophilized poly(EG-b-(DMAEMA-co-BMA))-pDNA nanoparticles into tissue engineering scaffolds for in vivo gene therapy applications.
机译:新型聚(EG-b-(DMAEMA-co-BMA))-pDNA纳米颗粒在PBS中冻干和孵育后表现出稳定,并在体外有效转染细胞。除50 L外,N / P比为10和20的复合物冻干后的大小比Hpofectamine2000和PEI小,而转染效率则比PEI高。由指数拟合确定的聚集时间常数提供了定量证据,证明与Iipofectamine2000和PEI相比,聚(EG-b-(DMAEMA-co-BMA))复合物的稳定性提高了。未来的工作将涉及将冻干的聚(EG-b-(DMAEMA-co-BMA))-pDNA纳米颗粒整合到组织工程支架中,以进行体内基因治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号